ID: ALA5291277

Max Phase: Preclinical

Molecular Formula: C21H42N4O12

Molecular Weight: 542.58

Associated Items:

Representations

Canonical SMILES:  C[C@@H](O)[C@H]1O[C@H](O[C@H]2[C@H](O[C@@H]3O[C@H](CNC[C@@H](O)CO)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C21H42N4O12/c1-6(27)17-15(32)14(31)11(24)20(35-17)36-18-9(23)2-8(22)12(29)19(18)37-21-16(33)13(30)10(34-21)4-25-3-7(28)5-26/h6-21,25-33H,2-5,22-24H2,1H3/t6-,7-,8-,9+,10-,11-,12+,13-,14-,15+,16-,17-,18-,19-,20-,21+/m1/s1

Standard InChI Key:  QRDMZRCZYKPTLI-UERROVCWSA-N

Associated Targets(Human)

Premature termination codon 106 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Escherichia coli 133304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bacillus subtilis 32866 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DNA 609 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 542.58Molecular Weight (Monoisotopic): 542.2799AlogP: -7.28#Rotatable Bonds: 10
Polar Surface Area: 288.85Molecular Species: BASEHBA: 16HBD: 12
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 15#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.16CX Basic pKa: 9.59CX LogP: -6.90CX LogD: -11.29
Aromatic Rings: 0Heavy Atoms: 37QED Weighted: 0.12Np Likeness Score: 1.39

References

1. Guchhait S, Khononov A, Pieńko T, Belakhov V, Baasov T..  (2023)  Balancing Nonsense Mutation Readthrough and Toxicity of Designer Aminoglycosides for Treatment of Genetic Diseases.,  14  (6): [PMID:37312846] [10.1021/acsmedchemlett.3c00089]

Source